Role of c-Jun-N-Terminal Kinase in Pregnane X Receptor-Mediated Induction of Human Cytochrome P4503A4 In Vitro
Open Access
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 46 (4) , 397-404
Abstract
Cytochrome P450 CYP3A4 is the most abundant drug-metabolizing enzyme and is responsible for the metabolism of ∼50% of clinically available drugs. Induction of CYP3A4 impacts the disposition of its substrates and leads to harmful clinical consequences, such as failure of therapy. To prevent such undesirable consequences, the molecular mechanisms of regulation of CYP3A4 need to be fully understood. CYP3A4 induction is regulated primarily by the xenobiotic nuclear receptor pregnane-X receptor (PXR). After ligand binding, PXR is translocated to the nucleus, where it binds to the CYP3A4 promoter and induces its gene expression. PXR function is modulated by phosphorylation(s) by multiple kinases. In this study, we determined the role of the c-Jun N-terminal kinase (JNK) in PXR-mediated induction of CYP3A4 enzyme in vitro. Human liver carcinoma cells (HepG2) were transfected with CYP3A4 luciferase and PXR plasmids, followed by treatment with JNK inhibitor (SP600125; SP) and PXR activators rifampicin (RIF) or hyperforin. Our results indicate that SP treatment significantly attenuated PXR-mediated induction of CYP3A4 reporter activity, as well as gene expression and enzyme activity. JNK knockdown by siRNA (targeting both JNK 1 and 2) also attenuated CYP3A4 induction by RIF. Interestingly, SP treatment attenuated JNK activation by RIF. Furthermore, treatment with RIF increased PXR nuclear levels and binding to the CYP3A4 promoter; SP attenuated these effects. This study shows that JNK is a novel mechanistic regulator of CYP3A4 induction by PXR.Keywords
This publication has 72 references indexed in Scilit:
- Discovery of Potent and Selective Covalent Inhibitors of JNKChemistry & Biology, 2012
- Post-translational modification of pregnane x receptorPharmacological Research, 2011
- Pregnane X Receptor PXR Activates the GADD45β Gene, Eliciting the p38 MAPK Signal and Cell MigrationJournal of Biological Chemistry, 2011
- Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical librariesNature Biotechnology, 2009
- A Systematic Analysis of Predicted Phosphorylation Sites within the Human Pregnane X Receptor ProteinThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Cyclic AMP-dependent Protein Kinase Signaling Modulates Pregnane x Receptor Activity in a Species-specific MannerJournal of Biological Chemistry, 2009
- Cyclin-dependent Kinase 2 Negatively Regulates Human Pregnane X Receptor-mediated CYP3A4 Gene Expression in HepG2 Liver Carcinoma CellsJournal of Biological Chemistry, 2008
- Cell Signaling and Nuclear Receptors: New Opportunities for Molecular Pharmaceuticals in Liver DiseaseMolecular Pharmaceutics, 2007
- Rosiglitazone attenuates suppression of RXRα-dependent gene expression in inflamed liverJournal of Hepatology, 2007
- Infection of a human hepatoma cell line by hepatitis B virusProceedings of the National Academy of Sciences, 2002